6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... histoplasmosis (>10 cases ... with ARV (see Table ... #Treatment #management ... #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
the determined cause ... #differential #algorithm ... #management #cardiology ... #treatment #table ... #heartfailure #chf
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... please refer to Table ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
HIV-AIDS Early Stage ... days (BIII) Late-Stage ... Therapy: • Perform CSF ... pallidum #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
a person with infectious ... Please refer to the table ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology